FarmaKology’s Substack

Share this post

FarmaKology-4th COVID vaccine dose offers “marginal benefits” in healthy adults

www.farmakology.com

FarmaKology-4th COVID vaccine dose offers “marginal benefits” in healthy adults

FarmaKology
Mar 18, 2022
Share this post

FarmaKology-4th COVID vaccine dose offers “marginal benefits” in healthy adults

www.farmakology.com
FarmaKology-4th COVID vaccine dose offers “marginal benefits” in healthy adults
FarmaKology-4th COVID vaccine dose offers “marginal benefits” in healthy adults
Novo Banking
Novo Banking

Today's Company

Flare Therapeutics
Flare Therapeutics

Flare Therapeutics

Flare Therapeutics is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of our scientific founders, Flare’s team is leveraging the power of ‘switch sites’ as druggable regions that hold the control for predictable and profound changes in DNA transcription, and therefore, gene expression. Our drug discovery to target ‘switch sites’ has rapidly advanced, resulting in our pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology.

News

Sanofi moves forward with EUROAPI listing on Euronext Paris

Today marks a major milestone for EUROAPI, a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients* (API), as Sanofi’s Board of Directors unanimously proposed, on March 17th, to submit to its shareholders the distribution of circa 58% of the share capital of EUROAPI. In addition to the previously proposed €3.33 cash dividend per Sanofi share, this additional extraordinary dividend, exclusively in kind, is subject to shareholders approval at Sanofi’s May 3, 2022 Ordinary and Extraordinary Shareholders’ Meeting.

China's Triastek and Siemens to accelerate digital transformation of pharma industry

Triastek, Inc. and Siemens Ltd., China have signed a strategic collaboration agreement to provide digital technologies for the global pharmaceutical industry. Combining Triastek's industry-leading 3D printing and digital pharmaceutical technologies and Siemens' global leadership in automation and digitization is expected to lead to innovative and transformative solutions for the development and manufacturing of pharmaceuticals.

Viatris Defeats Biogen's Attempt to Revive Tecfidera Patent

 Viatris Inc. announced that it is pleased with the decision by the United States Court of Appeals for the Federal Circuit denying Biogen's request that the Court reconsider its prior decision affirming the invalidity of Biogen's U.S. Patent No. 8,399,514, covering Tecfidera®. Following the Court's denial of Biogen's rehearing petition, the '514 patent remains invalid. Viatris' subsidiary Mylan Pharmaceuticals, Inc.

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership upon novel JAK1 inhibitor LNK01001 

Simcere and Lynk Pharmaceuticals Co., Ltd. announced a strategic partnership to develop and commercialize a highly selective JAK1 inhibitor LNK01001 in China. Under the terms of the agreement, Lynk Pharmaceuticals is responsible for the development of the product. Simcere will obtain the exclusive rights to market LNK01001 for the indications of rheumatoid arthritis and ankylosing spondylitis in China, after completing the payment of all commercialization rights and interests.

Research & Study

Researchers study how gene expression changes in the brain in Alzheimer's disease

New peer-reviewed research shows no increased risk of serious COVID-19 infections in Kesimpta® (ofatumumab)-treated adults with multiple sclerosis

4th COVID vaccine dose offers “marginal benefits” in healthy adults

Folic acid could cut risk of dementia

Podcast

Stream Tackling drug development with Mike Rea by The MedTalk Podcast on desktop and mobile. Play over 265 million tracks for free on SoundCloud.

Job Opportunities

Medical Representative

Pharmacy Technician

clinical pharmacist

Pharmacist

Upcoming Webinar

Allergic Rhinitis and Sinusitis Management

Digital Solutions to Optimize Facility and Asset Management in Pharma & Biotech

How the use of manufacturing software is enabling pharma companies like BioNTech to accelerate development and production

Video

FarmaKology
FarmaKology
Share this post

FarmaKology-4th COVID vaccine dose offers “marginal benefits” in healthy adults

www.farmakology.com
Comments
TopNew

No posts

Ready for more?

© 2023 FarmaKology
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing